Abstract:Abstract Background MicroRNAs (miRNAs) play key roles in tumorigenesis and progression of gastric cancer (GC). miR-1269 has been reported to be upregulated in several cancers and plays a crucial role in carcinogenesis and cancer progression. However, the biological function of miR-1269 in human GC and its mechanism remain unclear and need to be further elucidated. Methods The expression of miR-1269 in GC tissues and cell lines was detected by quantitative real-time PCR (qRT-PCR). Target prediction programs (TargetScanHuman 7.2 and miRBase) and a dual-luciferase reporter assay were used to confirm that Ras-association domain family 9 (RASSF9) is a target gene of miR-1269. The expression of RASSF9 was measured by qRT-PCR and Western blotting in GC tissues. MTT and cell counting assays were used to explore the effect of miR-1269 on GC cell proliferation. The cell cycle and apoptosis were measured by flow cytometry. RASSF9 knockdown and overexpression were used to further verify the function of the target gene. Results We found that miR-1269 expression was upregulated in human GC tissues and cell lines. The overexpression of miR-1269 promoted GC cell proliferation and cell cycle G1-S transition and suppressed apoptosis. The inhibition of miR-1269 inhibited cell growth and G1-S transition and induced apoptosis. miR-1269 expression was inversely correlated with RASSF9 expression in GC tissues. RASSF9 was verified to be a direct target of miR-1269 by using a luciferase reporter assay. The overexpression of miR-1269 decreased RASSF9 expression at both the mRNA and protein levels, and the inhibition of miR-1269 increased RASSF9 expression. Importantly, silencing RASSF9 resulted in the same biological effects in GC cells as those induced by overexpression of miR-1269. Overexpression of RASSF9 reversed the effects of miR-1269 overexpression on GC cells. Both miR-1269 overexpression and RASSF9 silencing activated the AKT signaling pathway, which modulated cell cycle regulators (Cyclin D1 and CDK2). In contrast, inhibition of miR-1269 and RASSF9 overexpression inhibited the AKT signaling pathway. Moreover, miR-1269 and RASSF9 also regulated the Bax/Bcl-2 signaling pathway. Conclusions Our results demonstrate that miR-1269 promotes GC cell proliferation and cell cycle G1-S transition by activating the AKT signaling pathway and inhibiting cell apoptosis via regulation of the Bax/Bcl-2 signaling pathway by targeting RASSF9. Our findings indicate an oncogenic role of miR-1269 in GC pathogenesis and the potential use of miR-1269 in GC therapy.

MicroRNA-128b suppresses tumor growth and promotes apoptosis by targeting A2bR in gastric cancer.

miR-1286, a Tumor Suppressor of Gastric Cancer, Serves as a Promising Biomarker for Screening Gastric Cancer from Gastritis

MicroRNA-128 Contributes to the Progression of Gastric Carcinoma Through GAREM-mediated MAPK Signaling Activation

MiR-128b is down-regulated in gastric cancer and negatively regulates tumour cell viability by targeting PDK1/Akt/NF-κB axis

MicroRNA-1297 Inhibits Proliferation and Promotes Apoptosis in Gastric Cancer Cells by Downregulating CDC6 Expression.

Mir-1273H-5p Suppresses the Penetration and Pervasion of Gastric Cancer Cells Via Suppressing CXCL12 Expression

MicroRNA-129 Inhibits Gastric Cancer Cells Proliferation and Invasion by Targeting HMGA2

Microrna-128-3p Inhibits CD4+ Regulatory T Cells Enrichment by Targeting Interleukin 16 in Gastric Cancer

PGC-1α/SNAI1 axis regulates tumor growth and metastasis by targeting miR-128b in gastric cancer.

miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasis

Targeting miR-148b-5p Inhibits Immunity Microenvironment and Gastric Cancer Progression

The Tumor Suppressor Roles Of Mir-433 And Mir-127 In Gastric Cancer

P2.29 Mir-148A Has a Therapeutic Potential to Suppress Gastric Cancer Metastasis

MIR-1265 Regulates Cellular Proliferation and Apoptosis by Targeting Calcium Binding Protein 39 in Gastric Cancer And, Thereby, Impairing Oncogenic Autophagy.

miR-488 acts as a tumor suppressor gene in gastric cancer

MicroRNA Library-Based Functional Screening Identified Mir-137 As a Suppresser of Gastric Cancer Cell Proliferation

MicroRNA-1269 promotes cell proliferation via the AKT signaling pathway by targeting RASSF9 in human gastric cancer

MiRNA-219a-1-3p inhibits the malignant progression of gastric cancer and is regulated by DNA methylation

MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.

Mir-148b Inhibits Glycolysis in Gastric Cancer Through Targeting Slc2a1

Pgc-1 Alpha/Snai1 Axis Regulates Tumor Growth And Metastasis By Targeting Mir-128b In Gastric Cancer